MedPath
HSA Approval

OXY-NASE PAEDIATRIC NASAL SPRAY 0.025% w/v

SIN12295P

OXY-NASE PAEDIATRIC NASAL SPRAY 0.025% w/v

OXY-NASE PAEDIATRIC NASAL SPRAY 0.025% w/v

May 14, 2003

ZUELLIG PHARMA PTE. LTD.

ZUELLIG PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZUELLIG PHARMA PTE. LTD.
Licence HolderZUELLIG PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SPRAY

NASAL

Medical Information

R01AA05

oxymetazoline

Manufacturer Information

ZUELLIG PHARMA PTE. LTD.

HOE PHARMACEUTICALS SDN BHD

Active Ingredients

OXYMETAZOLINE HCl

0.025% w/v

Oxymetazoline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OXY-NASE PAEDIATRIC NASAL SPRAY 0.025% w/v - HSA Approval | MedPath